Hepcidin analogues and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9822157
SERIAL NO

14775469

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates, inter alia, to certain hepcidin peptide analogs, including peptides and dimers thereof, and to the use of the peptides and peptide dimers in the treatment and/or prevention of a variety of diseases, conditions or disorders, including treatment and/or prevention of iron overload diseases, which include hereditary hemochromatosis and iron-loading anemias, and other conditions and disorders described herein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROTAGONIST THERAPEUTICS INC7707 GATEWAY BOULEVARD NEWARK CA 94560-1160

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bourne, Gregory Thomas Jindalee, AU 32 359
Fog, Jacob Ulrik Bagsvaerd, DK 15 179
Frederick, Brian T Ben Lomond, US 10 138
Madala, Praveen Brisbane, AU 7 158
Smythe, Mark Leslie Bardon, AU 25 274
Tofteng, Shelton Anne Pernille Valby, DK 7 158
Vink, Simone Taringa, AU 9 193

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 21, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 21, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00